Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Archiv Der Pharmazie|July 16, 2025
Structure-Activity Relationships of Inactive-Conformation Binding EGFR Inhibitors: Linking the ATP and Allosteric PocketsSurbhi P Chitnis, Florian Wittlinger, Mareike Möllers, et al.Journal of Medicinal Chemistry|August 13, 2025
Profiling and Optimizing Targeted Covalent Inhibitors through EGFR-Guided StudiesTahereh Damghani, Surbhi P Chitnis, Omobolanle A Abidakun, et al.Cell Chemical Biology|October 12, 2023
Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitorDebanjan Bhattacharjee, Jaweria Bakar, Surbhi P Chitnis, et al.Communications Chemistry|February 20, 2024
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitorsFlorian Wittlinger, Blessing C Ogboo, Ekaterina Shevchenko, et al.Journal of Medicinal Chemistry|December 3, 2024
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase InhibitorsFlorian Wittlinger, Surbhi P Chitnis, Calvin D Pham, et al.Pageof 1